ARCHIVES

NIAID Advisors Ok Women & Infants Study Continuation

This article is from The Cancer Letter archive.

Vol. 18 No. 08 | February 21, 1992

Download PDF Visit The Full Archive

Related Articles

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

April 16, 1999

DCCR Community Oncology Program RFP Now Ready

April 27, 1979

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

NCI Conducting Four Epidemiology Studies On Radon

July 1, 1988

Arzerra Promising For Heavily Pre-Treated CLL Patients

December 26, 2008